by Rhoda Wilson, Expose News:
In August, a South African Court ordered the National Department of Health (“NDOH”) to release covid vaccine contracts and other related documents. At the beginning of September, the first batch of documents was released.
On Thursday 17 August 2023, the Pretoria High Court ruled in favour of the Health Justice Initiative’s (“HJI’s”) bid to compel the NDOH to provide access to all covid “vaccine” procurement contracts and other documents. The Court ordered that all covid vaccine contracts (“Part 1”) and negotiation-related documents (“Part 2”) must be made public within 10 court days of the Judgment.
TRUTH LIVES on at https://sgtreport.tv/
On 1 September, HJI issued a press statement saying that NDOH had handed documents for Part 1 to HJI’s legal team. NDOH has undertaken to share the remainder of the documents, Part 2, which it was ordered to disclose, and in agreement with HJI, by no later than 29 September 2023.
On 5 September, HJI held a press briefing after which they uploaded the Part 1 documents to their website HERE. The Part 1 documents comprise:
- COVAX Facility/Gavi Alliance – Committed Purchase Agreement (dated 11 December 2020).
- Janssen Pharmaceutica – Advance Purchase Agreement (26 February 2021).
- Janssen Pharmaceutica – Advance Purchase Agreement, Additional Doses (_ April 2021).
- Janssen Pharmaceutica – Term Sheet (19 November 2020).
- Pfizer – Manufacturing and Supply Agreement (30 March 2021).
- Pfizer – Amendment to Manufacturing and Supply Agreement (4 June 2021).
- Pfizer – Binding Term Sheet.
- Serum Institute of India – Vaccine Purchase Agreement (18 January 2021).
- Serum Institute of India – Term Sheet (7 January 2021).
It is worth noting that the HJI was launched in July 2020 in South Africa “to advocate for a more inclusive, equitable public health system, locally and globally, both during and beyond the pandemic.” It was established using all the verbiage of the Globalist agenda.
The founder of HJI is Fatima Hassan, a South African human rights lawyer and social justice activist. She is the former executive director of the Open Society Foundation of South Africa, founded by infamous globalist George Soros.
We can safely assume that HJI is under the influence, if not the control, of the Globalists.
Further reading: How the British Invented George Soros, Lew Rockwell, 19 June 2021
Pfizer Covid Vaccine Contract
In the March 2021 manufacturing and supply agreement (“vaccine contract”) between Pfizer and NDOH, there is a paragraph that admits the safety and the efficacy of Pfizer’s covid injection were unknown:
5.1 Purchaser Acknowledgement.
Purchaser acknowledges that the Vaccine and materials related to the Vaccine, and their components and constituent materials are being rapidly developed due to the emergency circumstances of the COVID-19 pandemic and will continue to be studied after provision of the Vaccine to Purchaser under this Agreement. Purchaser further acknowledges that the long-term effects and efficacy of the Vaccine are not currently known and that there may be adverse effects of the Vaccine that are not currently known. Further, to the extent applicable, Purchaser acknowledges that the Product shall not be serialized. [Emphasis our own.]
Manufacturing and Supply Agreement Between Pfizer Laboratories Proprietary Limited and the Government of the Republic of South Africa Acting Through the National Department of Health of South Africa ( “NDOH” ), 30 March 2021
Janssen Covid Vaccine Contract
The NDOH contract with Janssen shows a similar lack of confidence in the “safety and efficacy” of its covid injection.
The Janssen covid injection was developed by Janssen Vaccines in Leiden, Netherlands, and its Belgian parent company Janssen Pharmaceuticals, a subsidiary of American company Johnson & Johnson (“J&J”).
The South African government signed two agreements with Janssen. The first was an ‘Advance Purchase Agreement’ dated 26 February 2021, to secure 11 million doses, followed by a second for the supply of additional doses on an unspecified date in April 2021.
Additional Vaccine Volume
5.2 The Government Purchaser acknowledges and agrees that:
(b) the final total dosage and administration schedule of COVID Vaccine required to protect one (I) individual against SARS-CoV-2/COVID-19 has not been determined as of the Effective Date [xx April 2021] and, without prejudice to clause 5.2(c), shall be determined solely by Janssen based on data generated in ongoing clinical trials; Janssen shall be entitled to unilaterally adjust the definition of Vaccine Dose set out in this Agreement after the Effective Date based on data generated as part of its ongoing clinical trials. [pg.12]
(c) Janssen provides no warranty that a Vaccine Dose will be sufficient to protect one (I) individual against COVID-19, or that the COVID Vaccine is safe or efficacious [pg.12]
13.4 … Janssen disclaims, to the fullest extent permitted by Law, all warranties … relating to the sufficiency of a single Vaccine Dose to protect one (I) individual against SARS-Co V-2/COVID-l 9 or the safety or effectiveness of the COVID Vaccine. [pg. 22] [Emphasis our own.]
Advance Purchase Agreement for SARS-CoV-2/Covid-19 Vaccine (Additional Doses), Janssen Pharmacuetica JV and the Government of the Republic of South Africa Acting Through the National Department of Health (the “Government Purchaser”), April 2021
Notably, on the ‘Additional Doses’ purchase agreement’s title page is an EMEA document reference. EMEA refers to Europe, the Middle East, and Africa, a geographical grouping used by global corporations to define regional business activity. Does this mean that Janssen used the same contract for all countries in the EMEA region?
According to Wikipedia, South Africa began its mass covid injection campaign on 17 February 2021. This is not true. It is more than a week before NDOH signed its first contract to purchase injections on 26 February. The date Wikipedia gives is, in fact, the date when the trial for Janssen’s vaccine in South Africa began.
The trial participants were healthcare workers, whether they realised they were taking part in a trial or not. In the week ending 21 February, nearly 15,000 people had been injected as part of J&J’s Sisonke covid vaccine trial. By the end of the following week, 28 February, more than 71,000 healthcare workers had been injected as part of the Sisonke trial.
Enrolment in the Siskone study began on 17 February 2021 and as of 12 April 2021, a total of 288,368 healthcare workers had received J&J’s Ad26.COV2.S vaccine, among whom 5898 (2%) reported adverse events. Fifty of the trial participants, in other words, healthcare workers, had serious side effects including 12 people who had allergic reactions and six who had neurologic conditions, including a case of Guillain-Barre syndrome and another with Bell’s palsy. The majority (85%) of participants experienced mild to moderate effects.
In April 2021, South Africa suspended the use of J&J covid injections as a “precautionary measure” and J&J delayed its European vaccine rollout following an FDA decision to pause the jabs while blood clot cases are examined. A few days later, South Africa announced it had resumed its J&J vaccination rollout.
The trial’s early safety data was reported in the New England Journal of Medicine in June 2021. The authors noted that no cases of the blood clotting condition, known as vaccine-induced immune thrombotic thrombocytopenia (“VITT”), were detected in the South African study. Although, around 28 cases had been identified in vaccinated people in other countries. However, five participants in the Sisonke study did develop blood clots – four of the five cases were linked to the vaccine, while one case was possibly linked.
In June 2021, there was a delay in the South African rollout of the J&J vaccine after it was found that there was a lack of adherence to proper standards at a manufacturing plant in the United States, News24 reported. The J&J injections intended for South Africa were suspended following a US ruling that ingredients for the country’s doses may have been contaminated during production in a plant in Baltimore. The US Food and Drug Administration said on 11 June 2021 that some batches of the J&J “vaccine” were not fit to use.
Did the Government Fully Inform the Public?
Did the South African government fully inform the public about the lack of safety and efficacy? No. In fact, the Government did the opposite.
On its website, the South African government assured the public that the injections were “safe and effective.” There is no indication of the date the webpage was uploaded or when it was last updated, however, it is clear it is before the public had been subjected to any of the injections:
The first doses of the vaccine are from Johnson & Johnson as its vaccine has proved effective … The country has secured 11 million doses of the Johnson & Johnson vaccine. [The ‘Advance Purchase Agreement’ with J&J is dated 26 February 2021.]
Vaccines undergo rigorous trials to ensure they are safe and effective. All vaccines go through a comprehensive approval process by medical regulators to ensure that they are safe. Pharmaceutical companies hand over all laboratory studies and safety trials to validate that the vaccine does work.
South Africa reached an agreement with the COVAX Facility to secure 12 million vaccine doses. This will be complemented by other vaccines that are available to South Africa through the African Union’s African Vaccine Acquisition Task Team facility. Pfizer has committed 20 million vaccine doses commencing with deliveries at the end of the first quarter. Government continues to work with various pharmaceutical companies to ensure we immunise 67 per cent of the population.
COVID-19 Coronavirus vaccine, South African Government
We don’t know what Part 2, the remaining documents given to HIJ, may reveal, but from the vaccine contracts alone it is apparent that the South African public was lied to. They were told the covid injections were “safe and effective” when the Government knew they had no basis to make that assertion.
Originally Posted at www.sgtreport.com